Research ArticleBrief Communication
Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial
Hui Chen, Gang Nan, Ding Wei, Ren-You Zhai, Ming Huang, Wu-Wei Yang, Bao-Cai Xing, Xu Zhu, Hai-Feng Xu, Xiao-Dong Wang, Xiao-Yong Zhang, Bao-Rang Zhu, Peng Liu, Guang Cao, Song Gao, Chun-Yi Hao, Ren-Jie Yang, Jian-Hai Guo, Xin Zhang, Kun Gao, Kun Wang, Jian-Feng Wang, Zi-Yu Li, Lin-Zhong Zhu, Rong Ding, Jing Li, Ling Zhao, Yu-Jun Shao, Hai-Chun Liu, Jie-Lai Xia, Ling Wang, Ling-Min Kong, Zhi-Nan Chen and Huijie Bian
Journal of Nuclear Medicine April 2022, 63 (4) 556-559; DOI: https://doi.org/10.2967/jnumed.121.262136
Hui Chen
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Gang Nan
2National Translational Science Center for Molecular Medicine and Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China;
Ding Wei
2National Translational Science Center for Molecular Medicine and Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China;
Ren-You Zhai
3Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China;
Ming Huang
4Yunnan Cancer Hospital, Third Affiliated Hospital of Kunming Medical University, Kunming, China;
Wu-Wei Yang
5Fifth Medical Center, Chinese PLA General Hospital, Beijing, China;
Bao-Cai Xing
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Xu Zhu
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Hai-Feng Xu
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Xiao-Dong Wang
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Xiao-Yong Zhang
6China Nuclear Industry Beijing 401 Hospital, Beijing, China; and
Bao-Rang Zhu
5Fifth Medical Center, Chinese PLA General Hospital, Beijing, China;
Peng Liu
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Guang Cao
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Song Gao
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Chun-Yi Hao
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Ren-Jie Yang
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Jian-Hai Guo
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Xin Zhang
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Kun Gao
3Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China;
Kun Wang
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Jian-Feng Wang
3Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China;
Zi-Yu Li
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Lin-Zhong Zhu
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
Rong Ding
4Yunnan Cancer Hospital, Third Affiliated Hospital of Kunming Medical University, Kunming, China;
Jing Li
5Fifth Medical Center, Chinese PLA General Hospital, Beijing, China;
Ling Zhao
4Yunnan Cancer Hospital, Third Affiliated Hospital of Kunming Medical University, Kunming, China;
Yu-Jun Shao
6China Nuclear Industry Beijing 401 Hospital, Beijing, China; and
Hai-Chun Liu
6China Nuclear Industry Beijing 401 Hospital, Beijing, China; and
Jie-Lai Xia
7College of Military Preventive Medicine, Fourth Military Medical University, Xi’an, China
Ling Wang
7College of Military Preventive Medicine, Fourth Military Medical University, Xi’an, China
Ling-Min Kong
2National Translational Science Center for Molecular Medicine and Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China;
Zhi-Nan Chen
2National Translational Science Center for Molecular Medicine and Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China;
Huijie Bian
2National Translational Science Center for Molecular Medicine and Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China;
Article Figures & Data
Figures
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue 4
April 1, 2022
Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial
Hui Chen, Gang Nan, Ding Wei, Ren-You Zhai, Ming Huang, Wu-Wei Yang, Bao-Cai Xing, Xu Zhu, Hai-Feng Xu, Xiao-Dong Wang, Xiao-Yong Zhang, Bao-Rang Zhu, Peng Liu, Guang Cao, Song Gao, Chun-Yi Hao, Ren-Jie Yang, Jian-Hai Guo, Xin Zhang, Kun Gao, Kun Wang, Jian-Feng Wang, Zi-Yu Li, Lin-Zhong Zhu, Rong Ding, Jing Li, Ling Zhao, Yu-Jun Shao, Hai-Chun Liu, Jie-Lai Xia, Ling Wang, Ling-Min Kong, Zhi-Nan Chen, Huijie Bian
Journal of Nuclear Medicine Apr 2022, 63 (4) 556-559; DOI: 10.2967/jnumed.121.262136
Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial
Hui Chen, Gang Nan, Ding Wei, Ren-You Zhai, Ming Huang, Wu-Wei Yang, Bao-Cai Xing, Xu Zhu, Hai-Feng Xu, Xiao-Dong Wang, Xiao-Yong Zhang, Bao-Rang Zhu, Peng Liu, Guang Cao, Song Gao, Chun-Yi Hao, Ren-Jie Yang, Jian-Hai Guo, Xin Zhang, Kun Gao, Kun Wang, Jian-Feng Wang, Zi-Yu Li, Lin-Zhong Zhu, Rong Ding, Jing Li, Ling Zhao, Yu-Jun Shao, Hai-Chun Liu, Jie-Lai Xia, Ling Wang, Ling-Min Kong, Zhi-Nan Chen, Huijie Bian
Journal of Nuclear Medicine Apr 2022, 63 (4) 556-559; DOI: 10.2967/jnumed.121.262136
Jump to section
Related Articles
Cited By...
- No citing articles found.